SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD

被引：0
|
作者：
Zekun Lu
Qiangsheng Hu
Yi Qin
Hao Yang
Bingkai Xiao
Weibo Chen
Shunrong Ji
Guangchen Zu
Zhiliang Wang
Guixiong Fan
Xiaowu Xu
Xuemin Chen
机构：
[1] the Third Affiliated Hospital of Soochow University,Department of Hepatopancreatobiliary Surgery
[2] Tongji University School of Medicine,Department of Thoracic Surgery, Shanghai Pulmonary Hospital
[3] Fudan University Shanghai Cancer Center,Department of Pancreatic Surgery
来源：
Cancer Cell International | / 23卷
关键词：
Ferroptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis
    Mao, Xiaoqi
    Xu, Jin
    Xiao, Mingming
    Liang, Chen
    Hua, Jie
    Liu, Jiang
    Wang, Wei
    Yu, Xianjun
    Meng, Qingcai
    Shi, Si
    REDOX BIOLOGY, 2024, 73
  • [42] BDE-209 induced spermatogenesis disorder by inhibiting SETD8/H4K20me1 related histone methylation in mice (vol 864, 161162, 2023)
    Li, Xiangyang
    Zhang, Yue
    Gao, Leqiang
    Yang, Xiaodi
    Zhou, Guiqing
    Sang, Yujian
    Xue, Jinglong
    Shi, Zhixiong
    Sun, Zhiwei
    Zhou, Xianqing
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 928
  • [43] Functional polymorphism at the miR-502-binding site in the 3′ untranslated region of the SETD8 gene increased the risk of prostate cancer in a sample of Iranian population
    Narouie, Behzad
    Ziaee, Seyed Amir Mohsen
    Basiri, Abbas
    Hashemi, Mohammad
    GENE, 2017, 626 : 354 - 357
  • [44] Expression of p8 in human pancreatic cancer
    Su, SB
    Motoo, Y
    Iovanna, JL
    Xie, MJ
    Mouri, H
    Ohtsubo, K
    Yamaguchi, Y
    Watanabe, H
    Okai, T
    Matsubara, F
    Sawabu, N
    CLINICAL CANCER RESEARCH, 2001, 7 (02) : 309 - 313
  • [45] Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer
    Chaudhary, Nazia
    Choudhary, Bhagya Shree
    Shah, Sanket Girish
    Khapare, Nileema
    Dwivedi, Nehanjali
    Gaikwad, Anagha
    Joshi, Neha
    Raichanna, Jinsy
    Basu, Srikanta
    Gurjar, Murari
    Smitha, P. K.
    Saklani, Avanish
    Gera, Poonam
    Ramadwar, Mukta
    Patil, Prachi
    Thorat, Rahul
    Gota, Vikram
    Dhar, Sujan K.
    Gupta, Sanjay
    Das, Manjula
    Dalal, Sorab N.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (07) : 1495 - 1511
  • [46] FTH1P8 induces and transmits docetaxel resistance by inhibiting ferroptosis in prostate cancer
    Lu, Junhong
    Zou, Qingrong
    Li, Yang
    Xiong, Chuanwei
    Tao, Lin
    Wu, Jiayuan
    Qin, Mei
    Yang, Jie
    He, Linhong
    Qin, Meichun
    Dong, Min
    Li, Yingxin
    Cao, Sisi
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
  • [47] BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
    Cao, Yizhi
    Wang, Xuelong
    Liu, Yang
    Liu, Pengyi
    Qin, Jiejie
    Zhu, Youwei
    Zhai, Shuyu
    Jiang, Yongsheng
    Liu, Yihao
    Han, Lijie
    Luo, Jiaxin
    Zhang, Ronghao
    Shi, Minmin
    Wang, Liwen
    Tang, Xiaomei
    Xue, Meilin
    Liu, Jia
    Wang, Weishen
    Wen, Chenlei
    Deng, Xiaxing
    Peng, Chenghong
    Chen, Hao
    Cheng, Dongfeng
    Jiang, Lingxi
    Shen, Baiyong
    ADVANCED SCIENCE, 2024, 11 (07)
  • [48] Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis
    Liu, Xing
    Peng, Xinhui
    Cen, Shuai
    Yang, Cuiting
    Ma, Zhijie
    Shi, Xinyuan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [49] Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells
    Wang, Kang
    Zhang, Zhengyang
    Wang, Ming
    Cao, Xiongfeng
    Qi, Jianchen
    Wang, Dongqing
    Gong, Aihua
    Zhu, Haitao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2135 - 2144
  • [50] Crocetin inhibits pancreatic cancer growth (vol 8, pg 315, 2009)
    Dhar, Animesh
    Mehta, Smita
    Dhar, Gopal
    Dhar, Kakali
    Banerjee, Snigdha
    Van Veldhuizen, Peter
    Campbell, Donald R.
    Banerjee, Sushanta K.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (03) : 711 - 711
12345